Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LEVOTHYROXINE 137 MCG TABLET

LEVOTHYROXINE SODIUM
$0.0650per EA

Strength

137 ug/1

Manufacturer

NorthStar Rx LLC

NDC

72603066701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA211417

On Market Since

4/8/2025

Pharmacological Classes

Thyroxine
l-Thyroxine

Price History

1W

0.0%

1M

-2.9%

3M

-12.9%

6M

-11.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-15.3%

Generic Alternatives

1 alternative • Same active ingredient

LEVOTHYROXINE 137 MCG TABLET
Generic
33342040010•Macleods Pharmaceuticals Limited
$0.0650

Related Drugs

Same classification

LEVOTHYROXINE 25 MCG TABLET
Generic
00378180010•Mylan Pharmaceuticals Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00378180077•Mylan Pharmaceuticals Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00480868210•Teva Pharmaceuticals USA Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00480868298•Teva Pharmaceuticals USA Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00527328043•Lannett Company Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00527328046•Lannett Company Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
00904694961•Major Pharmaceuticals
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
16729044715•Accord Healthcare Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
16729044717•Accord Healthcare Inc.
$0.0380
per EA
LEVOTHYROXINE 25 MCG TABLET
Generic
31722028410•Camber Pharmaceuticals Inc.
$0.0380
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy